Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Procept (PRCT) Q2 Revenue Jumps 48%
Procept (PRCT) Q2 Revenue Jumps 48%

Procept BioRobotics (NASDAQ:PRCT), a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia (BPH) treatment, posted second-quarter 2025 results on

Verra Mobility (VRRM) Q2 Revenue Up 6%
Verra Mobility (VRRM) Q2 Revenue Up 6%

Verra Mobility (NASDAQ:VRRM), a leader in smart mobility technology serving commercial fleets and government agencies, released its second-quarter results on August 6, 2025. The headline news from

Zentalis (ZNTL) Q2 Loss Narrows 70%
Zentalis (ZNTL) Q2 Loss Narrows 70%

Zentalis Pharmaceuticals (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company focused on developing cancer therapies, released its second quarter earnings on August 6, 2025. The headline news

Astec (ASTE) Q2 EPS Jumps 59%
Astec (ASTE) Q2 EPS Jumps 59%

Astec Industries (NASDAQ:ASTE), a leading manufacturer of equipment for road building and aggregate processing, reported results for Q2 2025 on August 6, 2025. In this report, the company delivered

Mativ (MATV) Q2 EPS Jumps 83%
Mativ (MATV) Q2 EPS Jumps 83%

Mativ (NYSE:MATV), a manufacturer of specialty materials and solutions for filtration, packaging, and adhesives, released its Q2 2025 results on August 6, 2025. The company outpaced analyst

Soleno (SLNO) Q2 Revenue Jumps 30%
Soleno (SLNO) Q2 Revenue Jumps 30%

Soleno Therapeutics (NASDAQ:SLNO), a biotech company focused on rare disease treatments, posted its inaugural commercial revenue following the U.S. launch of VYKAT XR for Prader-Willi syndrome

NewAmsterdam (NAMS) Q2 Revenue Jumps 49%
NewAmsterdam (NAMS) Q2 Revenue Jumps 49%

NewAmsterdam Pharma (NASDAQ:NAMS), a clinical-stage biopharmaceutical company focused on developing oral therapies for cardiometabolic diseases, delivered its Q2 2025 earnings report on August 6

Vaxcyte (PCVX) Q2 Loss Widens 11%
Vaxcyte (PCVX) Q2 Loss Widens 11%

Vaxcyte (NASDAQ:PCVX), a biotechnology company specializing in next-generation vaccines, reported its second quarter 2025 results on August 6, 2025. The company reported a GAAP net loss per share of

Symbotic (SYM) Q3 Revenue Jumps 26%
Symbotic (SYM) Q3 Revenue Jumps 26%

Symbotic (NASDAQ:SYM), a warehouse automation technology provider, delivered its third quarter fiscal 2025 earnings on August 6, 2025. Symbotic achieved GAAP revenue of $592 million for Q3 FY2025

Extreme (EXTR) Q4 Revenue Jumps 20%
Extreme (EXTR) Q4 Revenue Jumps 20%

Extreme Networks (NASDAQ:EXTR), a provider of cloud-managed networking solutions and services, reported its Q4 FY2025 financial results on August 6, 2025. The headline news: The company beat Wall

Amtech (ASYS) Q3 Revenue Beats by 15%
Amtech (ASYS) Q3 Revenue Beats by 15%

Amtech Systems (NASDAQ:ASYS), a supplier of thermal processing and semiconductor equipment, reported its fiscal third quarter results on August 6, 2025. The company’s earnings release highlighted a

Smith Micro (SMSI) Q2 Loss Narrows 63%
Smith Micro (SMSI) Q2 Loss Narrows 63%

Smith Micro Software (NASDAQ:SMSI), a provider of software solutions for digital family safety and wireless services, released its second quarter 2025 earnings on August 6, 2025. The report

Warrior Met Coal (HCC) Q2 EPS Beats View
Warrior Met Coal (HCC) Q2 EPS Beats View

Warrior Met Coal (NYSE:HCC), a leading producer of premium steelmaking coal headquartered in Alabama, reported its earnings for the second quarter on August 6, 2025. Warrior surprised analysts with

Root (ROOT) Q2 Net Income Hits $22M
Root (ROOT) Q2 Net Income Hits $22M

Root (NASDAQ:ROOT), the technology-driven auto insurer, reported its financial results for the second quarter of fiscal 2025 on August 6, 2025. The report showed a clear return to profitability, as

Oscar Health (OSCR) Q2 Revenue Rises 29%
Oscar Health (OSCR) Q2 Revenue Rises 29%

Oscar Health (NYSE:OSCR), a technology-focused health insurance provider, released results for the second quarter of 2025 on August 6, 2025, offering a mix of headline growth and operational

Perrigo (PRGO) Q2 EPS Rises 7.5%
Perrigo (PRGO) Q2 EPS Rises 7.5%

Perrigo (NYSE:PRGO), a major supplier of over-the-counter (OTC) self-care products across North America and Europe, released its Q2 FY2025 financial results on August 6, 2025. The company posted

Neumora (NMRA) Q2 Loss Improves 10%
Neumora (NMRA) Q2 Loss Improves 10%

Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage neuroscience company developing targeted therapies for brain diseases, released its second quarter 2025 results on August 6, 2025. The most

NextNav (NN) Q2 Loss Widens 159%
NextNav (NN) Q2 Loss Widens 159%

NextNav (NASDAQ:NN), a provider of advanced 3D positioning, navigation, and timing (PNT) solutions, released its earnings for the quarter ended June 30, 2025, on August 6, 2025. The company reported

CareTrust REIT (CTRE) Q2 Revenue Up 63%
CareTrust REIT (CTRE) Q2 Revenue Up 63%

CareTrust REIT (NYSE:CTRE), a real estate investment trust focused on healthcare properties, released its latest earnings results on August 6, 2025, for Q2 FY2025. The company reported GAAP revenue

Entrada (TRDA) Q2 Revenue Drops 98%
Entrada (TRDA) Q2 Revenue Drops 98%

Entrada Therapeutics (NASDAQ:TRDA), a biotechnology company developing intracellular therapies for rare neuromuscular diseases, reported second quarter 2025 financial results on August 6, 2025. The

ESAB (ESAB) Q2 Revenue Jumps 6%
ESAB (ESAB) Q2 Revenue Jumps 6%

ESAB (NYSE:ESAB), a leading global provider of fabrication technology and gas control solutions, reported Q2 2025 results on August 6, 2025. The most notable headline: GAAP revenue for Q2 2025 was

Bloomin' Brands (BLMN) Q2 EPS Tops Views
Bloomin' Brands (BLMN) Q2 EPS Tops Views

Bloomin' Brands (NASDAQ:BLMN), the restaurant group behind Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s, reported financial results for Q2 FY2025 on August 6, 2025

New York Times (NYT) Q2 EPS Jumps 29%
New York Times (NYT) Q2 EPS Jumps 29%

The New York Times Co. (NYSE:NYT), the publisher behind the namesake newspaper and a suite of digital products, reported earnings on August 6, 2025. The company posted adjusted diluted earnings per

STAAR Surgical (STAA) Q2 Revenue Tops 9%
STAAR Surgical (STAA) Q2 Revenue Tops 9%

STAAR Surgical (NASDAQ:STAA), a medical device company specializing in implantable lenses for vision correction, released its earnings for Q2 FY2025 on August 6, 2025. The main news from the release

Townsquare (TSQ) Q2 Revenue Slips 2%
Townsquare (TSQ) Q2 Revenue Slips 2%

Townsquare Media (NYSE:TSQ), a local media and digital marketing company focused on mid-sized markets, released its second quarter 2025 earnings on August 6, 2025. The company’s most notable news